[English] 日本語
Yorodumi
- PDB-6hl0: Crystal Structure of Farnesoid X receptor (FXR) with bound NCoA-2... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 6hl0
TitleCrystal Structure of Farnesoid X receptor (FXR) with bound NCoA-2 peptide
Components
  • Bile acid receptor
  • NCoA-2 peptide (Nuclear receptor coactivator 2), LYS-GLU-ASN-ALA-LEU-LEU-ARG-TYR-LEU-LEU-ASP-LYS-ASP
KeywordsNUCLEAR PROTEIN / Activator / DNA-binding / Receptor / Repressor / Complex
Function / homology
Function and homology information


: / chenodeoxycholic acid binding / positive regulation of phosphatidic acid biosynthetic process / : / positive regulation of ammonia assimilation cycle / regulation of low-density lipoprotein particle clearance / intracellular triglyceride homeostasis / cellular response to bile acid / negative regulation of very-low-density lipoprotein particle remodeling / negative regulation of interleukin-1 production ...: / chenodeoxycholic acid binding / positive regulation of phosphatidic acid biosynthetic process / : / positive regulation of ammonia assimilation cycle / regulation of low-density lipoprotein particle clearance / intracellular triglyceride homeostasis / cellular response to bile acid / negative regulation of very-low-density lipoprotein particle remodeling / negative regulation of interleukin-1 production / regulation of bile acid biosynthetic process / regulation of insulin secretion involved in cellular response to glucose stimulus / negative regulation of monocyte chemotactic protein-1 production / toll-like receptor 9 signaling pathway / nuclear receptor-mediated bile acid signaling pathway / bile acid nuclear receptor activity / bile acid metabolic process / bile acid binding / cell-cell junction assembly / cellular response to fatty acid / regulation of cholesterol metabolic process / negative regulation of interleukin-2 production / bile acid and bile salt transport / intracellular glucose homeostasis / positive regulation of interleukin-17 production / negative regulation of interleukin-6 production / negative regulation of type II interferon production / Synthesis of bile acids and bile salts / negative regulation of tumor necrosis factor production / Synthesis of bile acids and bile salts via 27-hydroxycholesterol / negative regulation of tumor necrosis factor-mediated signaling pathway / Endogenous sterols / Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol / positive regulation of insulin receptor signaling pathway / fatty acid homeostasis / positive regulation of insulin secretion involved in cellular response to glucose stimulus / nuclear retinoid X receptor binding / Recycling of bile acids and salts / intracellular receptor signaling pathway / Notch signaling pathway / positive regulation of adipose tissue development / negative regulation of canonical NF-kappaB signal transduction / cholesterol homeostasis / nuclear receptor binding / transcription coregulator binding / RNA polymerase II transcription regulatory region sequence-specific DNA binding / SUMOylation of intracellular receptors / euchromatin / PPARA activates gene expression / Nuclear Receptor transcription pathway / negative regulation of inflammatory response / RNA polymerase II transcription regulator complex / nuclear receptor activity / cellular response to lipopolysaccharide / DNA-binding transcription activator activity, RNA polymerase II-specific / sequence-specific DNA binding / transcription by RNA polymerase II / DNA-binding transcription factor activity, RNA polymerase II-specific / cell differentiation / receptor complex / transcription cis-regulatory region binding / defense response to bacterium / nuclear speck / RNA polymerase II cis-regulatory region sequence-specific DNA binding / inflammatory response / DNA-binding transcription factor activity / innate immune response / regulation of DNA-templated transcription / regulation of transcription by RNA polymerase II / negative regulation of apoptotic process / chromatin / positive regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II / positive regulation of transcription by RNA polymerase II / zinc ion binding / nucleoplasm / nucleus / cytosol
Similarity search - Function
Bile acid receptor, ligand binding domain / Thyroid hormone receptor / : / Retinoid X Receptor / Retinoid X Receptor / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Double treble clef zinc finger, C4 type / Nuclear hormone receptors DNA-binding domain profile. ...Bile acid receptor, ligand binding domain / Thyroid hormone receptor / : / Retinoid X Receptor / Retinoid X Receptor / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Double treble clef zinc finger, C4 type / Nuclear hormone receptors DNA-binding domain profile. / c4 zinc finger in nuclear hormone receptors / Nuclear hormone receptor, ligand-binding domain / Nuclear hormone receptor-like domain superfamily / Ligand-binding domain of nuclear hormone receptor / Nuclear receptor (NR) ligand-binding (LBD) domain profile. / Ligand binding domain of hormone receptors / Zinc finger, NHR/GATA-type / Orthogonal Bundle / Mainly Alpha
Similarity search - Domain/homology
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.66 Å
AuthorsKudlinzki, D. / Merk, D. / Linhard, V.L. / Saxena, K. / Schubert-Zsilavecz, M. / Schwalbe, H.
CitationJournal: Nat Commun / Year: 2019
Title: Molecular tuning of farnesoid X receptor partial agonism.
Authors: Merk, D. / Sreeramulu, S. / Kudlinzki, D. / Saxena, K. / Linhard, V. / Gande, S.L. / Hiller, F. / Lamers, C. / Nilsson, E. / Aagaard, A. / Wissler, L. / Dekker, N. / Bamberg, K. / Schubert- ...Authors: Merk, D. / Sreeramulu, S. / Kudlinzki, D. / Saxena, K. / Linhard, V. / Gande, S.L. / Hiller, F. / Lamers, C. / Nilsson, E. / Aagaard, A. / Wissler, L. / Dekker, N. / Bamberg, K. / Schubert-Zsilavecz, M. / Schwalbe, H.
History
DepositionSep 10, 2018Deposition site: PDBE / Processing site: PDBE
Revision 1.0May 29, 2019Provider: repository / Type: Initial release
Revision 1.1Jul 17, 2019Group: Data collection / Database references / Category: citation / citation_author
Item: _citation.country / _citation.journal_abbrev ..._citation.country / _citation.journal_abbrev / _citation.journal_id_CSD / _citation.journal_id_ISSN / _citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_DOI / _citation.pdbx_database_id_PubMed / _citation.title / _citation.year
Revision 1.2Jan 24, 2024Group: Data collection / Database references / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Bile acid receptor
B: NCoA-2 peptide (Nuclear receptor coactivator 2), LYS-GLU-ASN-ALA-LEU-LEU-ARG-TYR-LEU-LEU-ASP-LYS-ASP


Theoretical massNumber of molelcules
Total (without water)28,7532
Polymers28,7532
Non-polymers00
Water2,522140
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: gel filtration, Protein/Peptide Complex
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area1080 Å2
ΔGint-7 kcal/mol
Surface area12520 Å2
MethodPISA
Unit cell
Length a, b, c (Å)85.359, 34.558, 82.880
Angle α, β, γ (deg.)90.00, 103.05, 90.00
Int Tables number5
Space group name H-MC121

-
Components

#1: Protein Bile acid receptor / Farnesoid X-activated receptor / Farnesol receptor HRR-1 / Nuclear receptor subfamily 1 group H ...Farnesoid X-activated receptor / Farnesol receptor HRR-1 / Nuclear receptor subfamily 1 group H member 4 / Retinoid X receptor-interacting protein 14 / RXR-interacting protein 14


Mass: 27159.209 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Details: Protein Domain / Source: (gene. exp.) Homo sapiens (human) / Gene: NR1H4, BAR, FXR, HRR1, RIP14 / Production host: Escherichia coli BL21(DE3) (bacteria) / References: UniProt: Q96RI1
#2: Protein/peptide NCoA-2 peptide (Nuclear receptor coactivator 2), LYS-GLU-ASN-ALA-LEU-LEU-ARG-TYR-LEU-LEU-ASP-LYS-ASP


Mass: 1593.844 Da / Num. of mol.: 1 / Source method: obtained synthetically / Details: Polypeptide / Source: (synth.) Homo sapiens (human)
#3: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 140 / Source method: isolated from a natural source / Formula: H2O

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.28 Å3/Da / Density % sol: 40.6 %
Crystal growTemperature: 277 K / Method: vapor diffusion, sitting drop / pH: 7.5
Details: 50 mM Ca(CH3COO)2, 10 mM DTT, 25-30% PEG 3350, 100 mM Tris

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: BESSY / Beamline: 14.2 / Wavelength: 0.91841 Å
DetectorType: RAYONIX MX-225 / Detector: CCD / Date: Nov 30, 2013
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.91841 Å / Relative weight: 1
ReflectionResolution: 1.66→41.58 Å / Num. obs: 26862 / % possible obs: 95.5 % / Redundancy: 3.6 % / CC1/2: 0.996 / Rmerge(I) obs: 0.119 / Rpim(I) all: 0.073 / Rrim(I) all: 0.14 / Net I/σ(I): 6.8
Reflection shellResolution: 1.66→1.75 Å / Redundancy: 2.7 % / Mean I/σ(I) obs: 0.3 / Num. unique obs: 2941 / CC1/2: 0.123 / % possible all: 74

-
Processing

Software
NameVersionClassification
PHENIX(1.10.1_2155: ???)refinement
XDSdata reduction
SCALAdata scaling
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 4QE6

4qe6
PDB Unreleased entry


Resolution: 1.66→41.578 Å / SU ML: 0.27 / Cross valid method: FREE R-VALUE / σ(F): 1.35 / Phase error: 33.32
RfactorNum. reflection% reflection
Rfree0.2458 760 2.83 %
Rwork0.2153 --
obs0.2161 26860 95.15 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å
Refinement stepCycle: LAST / Resolution: 1.66→41.578 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms2007 0 0 141 2148
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0072055
X-RAY DIFFRACTIONf_angle_d0.8982774
X-RAY DIFFRACTIONf_dihedral_angle_d19.2071264
X-RAY DIFFRACTIONf_chiral_restr0.054311
X-RAY DIFFRACTIONf_plane_restr0.007356
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
1.6601-1.78820.36341140.35274132X-RAY DIFFRACTION76
1.7882-1.96820.35851550.31265390X-RAY DIFFRACTION99
1.9682-2.2530.29241400.2385476X-RAY DIFFRACTION100
2.253-2.83840.2451760.21285488X-RAY DIFFRACTION100
2.8384-41.59060.20881750.17525614X-RAY DIFFRACTION100
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
12.51280.3439-1.25793.6040.27336.76720.0131-0.0233-0.03430.0860.0226-0.11460.57480.4158-0.01090.2645-0.00850.02850.150.00190.1989-20.382-26.8942113.5393
28.18982.1088-4.72643.6738-1.76035.3273-0.14770.0106-1.130.3539-0.2890.26520.0322-0.20770.38630.33790.02240.09410.28930.01790.4767-8.0396-23.931484.5477
33.3222-0.1304-2.20361.51670.24234.4157-0.07110.1069-0.1017-0.0679-0.12790.1378-0.0428-0.30770.16210.18680.0072-0.03990.1672-0.00840.1703-19.8146-13.224395.639
44.2399-1.8858-0.70245.27651.11633.4809-0.01350.1358-0.3148-0.4522-0.0419-0.35410.07220.320.01110.2195-0.07520.03740.30910.01390.2453-8.4805-16.873899.2411
51.11360.8692-0.15041.28710.33323.4257-0.09480.1291-0.16640.09150.0642-0.251-0.04110.19190.05090.16490.0177-0.00270.38440.0630.31930.5935-15.594294.7281
64.8162-3.39481.44886.8332-1.07673.1335-0.22780.1627-0.0760.36470.1596-0.1296-0.1825-0.00820.08270.2322-0.0410.00490.1507-0.02420.1278-16.6006-13.2709108.0456
72.4124-0.85562.07172.0349-1.48922.9303-0.1814-0.19540.00250.43490.1407-0.0847-0.2174-0.1232-0.00840.2235-0.0018-0.0090.1069-0.01010.1435-15.1687-17.745117.6585
80.1805-0.73880.87054.0062-5.85798.7675-0.11060.18460.17060.2906-0.1141-0.2915-0.60450.47590.29710.2385-0.0658-0.0440.24960.00650.2704-6.5053-7.4434104.5181
92.71860.61250.67283.6187-0.14742.74080.09490.71160.4577-0.7141-0.05-0.27390.2769-0.0554-0.01520.3250.0450.030.35940.0460.2826-12.482-4.360585.2451
107.497-0.08880.35532.557-0.1338.8616-0.0002-0.46220.09580.96540.113-0.0023-0.1234-0.0432-0.04960.24680.0032-0.0430.2685-0.00390.2303-29.6133-10.176591.9101
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection details
1X-RAY DIFFRACTION1chain 'A' and (resid 241 through 262 )
2X-RAY DIFFRACTION2chain 'A' and (resid 263 through 279 )
3X-RAY DIFFRACTION3chain 'A' and (resid 280 through 323 )
4X-RAY DIFFRACTION4chain 'A' and (resid 324 through 338 )
5X-RAY DIFFRACTION5chain 'A' and (resid 339 through 375 )
6X-RAY DIFFRACTION6chain 'A' and (resid 376 through 400 )
7X-RAY DIFFRACTION7chain 'A' and (resid 401 through 428 )
8X-RAY DIFFRACTION8chain 'A' and (resid 429 through 452 )
9X-RAY DIFFRACTION9chain 'A' and (resid 453 through 471 )
10X-RAY DIFFRACTION10chain 'B' and (resid 740 through 752 )

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more